Logo image of PCOR

PROCORE TECHNOLOGIES INC (PCOR) Stock Fundamental Analysis

USA - NYSE:PCOR - US74275K1088 - Common Stock

72.27 USD
+0.5 (+0.7%)
Last: 10/14/2025, 8:07:53 PM
72.27 USD
0 (0%)
After Hours: 10/14/2025, 8:07:53 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PCOR. PCOR was compared to 282 industry peers in the Software industry. While PCOR seems to be doing ok healthwise, there are quite some concerns on its profitability. PCOR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PCOR had positive earnings in the past year.
In the past year PCOR had a positive cash flow from operations.
PCOR had negative earnings in each of the past 5 years.
Each year in the past 5 years PCOR had a positive operating cash flow.
PCOR Yearly Net Income VS EBIT VS OCF VS FCFPCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

With a Return On Assets value of -7.12%, PCOR perfoms like the industry average, outperforming 41.84% of the companies in the same industry.
PCOR's Return On Equity of -11.72% is in line compared to the rest of the industry. PCOR outperforms 47.52% of its industry peers.
Industry RankSector Rank
ROA -7.12%
ROE -11.72%
ROIC N/A
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
PCOR Yearly ROA, ROE, ROICPCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of PCOR (80.17%) is better than 82.62% of its industry peers.
PCOR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PCOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.52%
GM growth 5Y0.14%
PCOR Yearly Profit, Operating, Gross MarginsPCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

PCOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PCOR has more shares outstanding
Compared to 5 years ago, PCOR has more shares outstanding
PCOR has a better debt/assets ratio than last year.
PCOR Yearly Shares OutstandingPCOR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
PCOR Yearly Total Debt VS Total AssetsPCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

PCOR has an Altman-Z score of 7.84. This indicates that PCOR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PCOR (7.84) is better than 78.01% of its industry peers.
The Debt to FCF ratio of PCOR is 0.38, which is an excellent value as it means it would take PCOR, only 0.38 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PCOR (0.38) is better than 79.79% of its industry peers.
PCOR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, PCOR is in the better half of the industry, outperforming 62.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.38
Altman-Z 7.84
ROIC/WACCN/A
WACC11.23%
PCOR Yearly LT Debt VS Equity VS FCFPCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.29 indicates that PCOR should not have too much problems paying its short term obligations.
PCOR has a Current ratio (1.29) which is comparable to the rest of the industry.
PCOR has a Quick Ratio of 1.29. This is a normal value and indicates that PCOR is financially healthy and should not expect problems in meeting its short term obligations.
PCOR's Quick ratio of 1.29 is in line compared to the rest of the industry. PCOR outperforms 42.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
PCOR Yearly Current Assets VS Current LiabilitesPCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The earnings per share for PCOR have decreased strongly by -12.63% in the last year.
Looking at the last year, PCOR shows a quite strong growth in Revenue. The Revenue has grown by 16.08% in the last year.
Measured over the past years, PCOR shows a very strong growth in Revenue. The Revenue has been growing by 31.83% on average per year.
EPS 1Y (TTM)-12.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.26%
Revenue 1Y (TTM)16.08%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%13.92%

3.2 Future

PCOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.32% yearly.
PCOR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.19% yearly.
EPS Next Y39.06%
EPS Next 2Y34.99%
EPS Next 3Y33.75%
EPS Next 5Y34.32%
Revenue Next Year13.7%
Revenue Next 2Y13.29%
Revenue Next 3Y13.81%
Revenue Next 5Y14.19%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PCOR Yearly Revenue VS EstimatesPCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PCOR Yearly EPS VS EstimatesPCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 87.07, PCOR can be considered very expensive at the moment.
PCOR's Price/Earnings ratio is in line with the industry average.
PCOR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.50.
A Price/Forward Earnings ratio of 42.19 indicates a quite expensive valuation of PCOR.
The rest of the industry has a similar Price/Forward Earnings ratio as PCOR.
PCOR is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 87.07
Fwd PE 42.19
PCOR Price Earnings VS Forward Price EarningsPCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

PCOR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 140.76
EV/EBITDA N/A
PCOR Per share dataPCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PCOR does not grow enough to justify the current Price/Earnings ratio.
PCOR's earnings are expected to grow with 33.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.23
PEG (5Y)N/A
EPS Next 2Y34.99%
EPS Next 3Y33.75%

0

5. Dividend

5.1 Amount

PCOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROCORE TECHNOLOGIES INC

NYSE:PCOR (10/14/2025, 8:07:53 PM)

After market: 72.27 0 (0%)

72.27

+0.5 (+0.7%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners94.44%
Inst Owner Change1.24%
Ins Owners8.81%
Ins Owner Change1.67%
Market Cap10.85B
Analysts77.24
Price Target82.88 (14.68%)
Short Float %7.57%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.54%
Min EPS beat(2)23.64%
Max EPS beat(2)31.45%
EPS beat(4)3
Avg EPS beat(4)-7.25%
Min EPS beat(4)-91.52%
Max EPS beat(4)31.45%
EPS beat(8)7
Avg EPS beat(8)63.01%
EPS beat(12)11
Avg EPS beat(12)68.81%
EPS beat(16)14
Avg EPS beat(16)54.52%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.65%
Revenue beat(4)3
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)1.65%
Revenue beat(8)7
Avg Revenue beat(8)1.37%
Revenue beat(12)11
Avg Revenue beat(12)2.11%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)0.01%
PT rev (3m)5.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.11%
EPS NY rev (1m)0.47%
EPS NY rev (3m)7.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 87.07
Fwd PE 42.19
P/S 8.81
P/FCF 140.76
P/OCF 65.71
P/B 8.91
P/tB 27.85
EV/EBITDA N/A
EPS(TTM)0.83
EY1.15%
EPS(NY)1.71
Fwd EY2.37%
FCF(TTM)0.51
FCFY0.71%
OCF(TTM)1.1
OCFY1.52%
SpS8.21
BVpS8.11
TBVpS2.6
PEG (NY)2.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.12%
ROE -11.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.17%
FCFM 6.26%
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.52%
GM growth 5Y0.14%
F-Score5
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.38
Debt/EBITDA N/A
Cap/Depr 85.55%
Cap/Sales 7.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 7.84
F-Score5
WACC11.23%
ROIC/WACCN/A
Cap/Depr(3y)77.64%
Cap/Depr(5y)76.37%
Cap/Sales(3y)6.24%
Cap/Sales(5y)5.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.26%
EPS Next Y39.06%
EPS Next 2Y34.99%
EPS Next 3Y33.75%
EPS Next 5Y34.32%
Revenue 1Y (TTM)16.08%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%13.92%
Revenue Next Year13.7%
Revenue Next 2Y13.29%
Revenue Next 3Y13.81%
Revenue Next 5Y14.19%
EBIT growth 1Y-46.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108.81%
EBIT Next 3Y51.75%
EBIT Next 5Y50.8%
FCF growth 1Y6974.59%
FCF growth 3Y138.66%
FCF growth 5YN/A
OCF growth 1Y252.36%
OCF growth 3Y74.8%
OCF growth 5YN/A